RGEN FY 2024 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$634M+0.3% YoY

Gross Profit

$275M43.3% margin

Operating Income

-$35M-5.5% margin

Net Income

-$26M-4.0% margin

EPS (Diluted)

$-0.46

Cash Flow

Operating Cash Flow

$175M

Free Cash Flow

$142M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$857M

Stockholders' Equity

$2.0B

Cash & Equivalents

$757M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$634M	$632M	+0.3%
Gross Profit	$275M	$278M	-1.4%
Operating Income	-$35M	$48M	-173.6%
Net Income	-$26M	$36M	-171.7%